- 020 3312 6254
Dr Nowlan Selvapatt is a consultant hepatologist and gastroenterologist working at Imperial College Healthcare NHS Trust. He graduated from Imperial College in 2006 and completed his specialist training in London, including Advanced Training Programme at King’s College Hospital Liver Transplant and Intensive Care Unit. He was awarded a PhD from Imperial College in 2017 for his research in Health Economic Analyses for Viral Hepatitis Screening Programmes.
In 2016 he was invited to write the World Health Organisation (WHO) guidelines on management of hepatitis C. He has particular interests in chronic liver disease, particularly cirrhosis. He is lead for inpatient liver care and provides liaison to intensive care. He has published numerous research papers including in complications of cirrhosis, and book chapters on acute on chronic liver failure. He regularly performs diagnostic and therapeutic upper GI endoscopies (OGD) and diagnostic colonoscopy including removal of polyps.
Dr Selvapatt’s research interests currently centre around aspects of care for patients with cirrhosis. He is currently involved in investigator led research studies and publishing original research in peer review journals as well as presentations at international conferences.
Liver disease, cirrhosis, alcohol related liver disease, fatty liver, liver cancer, autoimmune liver disease, viral hepatitis, endoscopy, colonoscopy
Research & publications
A selection of recent publications: In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19. 2020 PLoS One.
Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder. 2020 Lancet Gastroenterol Hepatol
Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection. World Health Organization 2016; ISBN: 978 92 4 154961 5 (guideline writer) Liver decompensation and Acute on Chronic Liver Failure. Liver Disease in Clinical Practice (Springer) – ISBN 978-3-319-43126-0 Is antenatal screening for hepatitis C virus cost-effective?
A decade's experience at a London centre. 2015 Journal of hepatology
Early diagnosis and treatment: the goal of hepatitis C screening 2015 British Medical Journal (BMJ)
Abdominal pain and weight loss: an uncommon outcome to a common referral.2012 Frontline Gastroenterol